| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 10/23/2008 | US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 10/23/2008 | US20080261921 Fused ring heterocycle kinase modulators |
| 10/23/2008 | US20080260754 Prevent transplant rejection; autoimmune diseases |
| 10/23/2008 | DE112006002147T5 Polymerverbindung und polymere lichtemittierende Vorrichtung diese verwendend Polymer compound and polymer light emitting device using this |
| 10/22/2008 | EP1981862A2 Lanthionine-related compounds for the treatment of inflammatory diseases |
| 10/22/2008 | CN101291676A Treatment of the symptoms of bladder irritation |
| 10/21/2008 | US7439238 Antiparasitic artemisinin derivatives (endoperoxides) |
| 10/16/2008 | WO2008124550A1 Phenothiazin derivatives for antiviral treatments |
| 10/16/2008 | WO2008021745A3 Hepatitis c virus entry inhibitors |
| 10/16/2008 | WO2007101007A3 Aryl sulfonyl heterocycles |
| 10/16/2008 | US20080255102 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence |
| 10/16/2008 | CA2686513A1 Antiviral treatments |
| 10/14/2008 | US7435732 Crystalline polymorphs of (3S)-N-hydroxy-4-({4-[-(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide |
| 10/09/2008 | WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof |
| 10/09/2008 | US20080248093 pH sensitive prodrugs of 2,6-diisopropylphenol |
| 10/08/2008 | CN101283019A Polymer and light-emitting polymer element using the same |
| 10/08/2008 | CN101279955A N-substituted thiamorpholine derivate as DPP-IV inhibitor and medical use thereof |
| 10/08/2008 | CN101279888A 9,10-divinyl anthracene derivate and application thereof to organic electroluminescent devices |
| 10/01/2008 | EP1480967B8 Fused ring compounds, and their use as cationic photoinitiators |
| 10/01/2008 | CN101273995A Method for preparing magnetic particles modified by afi-tiazin dyes and application |
| 09/30/2008 | US7429603 C-fms kinase inhibitors |
| 09/25/2008 | US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis |
| 09/24/2008 | CN101273049A A method of manufacturing an organic silicon compound that contains a methacryloxy group or an acryloxy group |
| 09/23/2008 | US7427683 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer |
| 09/23/2008 | US7427614 treatment of glaucoma or ocular hypertension; N-substituted hexahydropyrimidin-2-ones, perhydro-1,3-oxazin-2-ones and perhydro-1,3-thiazin-2-ones |
| 09/18/2008 | WO2008112674A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 09/17/2008 | EP1392639B1 Pyruvate derivatives |
| 09/16/2008 | US7425631 Compounds and methods of use |
| 09/16/2008 | US7425530 Stereoselective preparation of cyclic L-amino acids |
| 09/11/2008 | US20080221089 Compositions and methods for inhibition of the jak pathway |
| 09/11/2008 | US20080219929 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and/or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination |
| 09/10/2008 | EP1966132A2 Compounds which modulate the cb2 receptor |
| 09/10/2008 | CN100417641C Arylcycloalkyl derivatives having branched side chains used as ppar receptor regulator, processes for their preparation and their use as pharmaceuticals |
| 09/04/2008 | WO2008042755A3 Inhibitors of cognitive decline |
| 09/04/2008 | US20080214532 Carboxanilides as Microbiocides |
| 09/02/2008 | US7420053 2-imino-1,3-thiazine derivatives |
| 08/28/2008 | WO2008102908A1 Haloalkylsulfonanilide derivative |
| 08/28/2008 | US20080207604 Dtection compound that moderated tau-tau protein association; Alzheimer's disease; administering methylene blue |
| 08/28/2008 | US20080207603 Methods of Chemical Synthesis and Purification of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc) |
| 08/26/2008 | CA2532743C Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols |
| 08/21/2008 | US20080200672 Highly enantioselective carbonyl reduction with borane catalyzed by chiral spiroborate esters derived from chiral beta-aminoalcohols |
| 08/20/2008 | EP1667947B1 Methods of 11c -radiolabelling phenothiazine and pheno thiazine-like compounds |
| 08/20/2008 | EP1375489B1 Medicinal composition containing 1,3-thiazine derivative |
| 08/20/2008 | CN101248062A C-fms kinase inhibitors |
| 08/20/2008 | CN101247837A Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 08/19/2008 | US7414128 Crystalline R-guanidines, Arginine or (L)-Arginine (2S)-2-Ethoxy-3-{4-[2-(10H -phenoxazin-10-yl)ethoxy]phenyl}propanoate |
| 08/19/2008 | US7414052 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence |
| 08/13/2008 | EP1955697A1 2-aminobenzamide derivative |
| 08/13/2008 | EP1954288A1 Amidine derivatives and their uses as medicine |
| 08/12/2008 | US7411095 obtained using specific secondary amines are unexpectedly stable against water; reacting an aldehyde or ketone with an amine and treating the resulting reaction mixture with an acidic aqueous solution |
| 08/12/2008 | US7411093 e.g. 2-(2-methoxy-phenyl)-cyclohexylamine; dipeptidyl-peptidase inhibitor; antidiabetic agent; non-insulin dependent diabetes mellitus, and impaired glucose tolerance, obesity, metabolic syndrome or beta -cell protection |
| 08/12/2008 | US7411066 e.g. 6-Bromo-7-(naphtalen-1-ylmethyl)-5-oxo-8-cyclopropyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic Acid Methyl Ester; inhibit biofilm/pili formation and adherence of bacteria to a host cell |
| 08/12/2008 | US7410964 Cyclohexyl sulphones as gamma-secretase inhibitors |
| 08/12/2008 | CA2322158C Arylphenyl-substituted cyclic keto-enols |
| 08/07/2008 | US20080188462 reversed chloroquines; to treat chloroquine resistant/sensitive malaria parasites; N'-(7-Chloro-quinolin-4-yl)-N-[3-(10,11-dihydro-dibenzo[b,f]azepin-5-yl)-propyl]-N-methyl-propane-1,3-diamine |
| 08/06/2008 | CN101234315A Hollow granular thiophenylamine substance and preparation thereof |
| 08/05/2008 | US7407953 phenothiazinium compounds; for healing process and cosmetic uses; for problems associated with vascular disease, malnutrition, stress, cancer radio- or chemotherapy, compromise of immune system or due to normal aging process; as a cream, suspension, emulsion, gel, ointment, salve, stick, soap, paste |
| 07/30/2008 | EP1950207A1 Preparation of high purity phenothiazine n-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase activity |
| 07/30/2008 | CN100406892C Tau-Tau结合的抑制 Tau-Tau binding inhibition |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/24/2008 | WO2008073956A3 Cyclic sulfonamide derivatives and methods of their use |
| 07/24/2008 | WO2007120638A3 Methods and compositions for modulating glycosylation |
| 07/24/2008 | US20080176838 e.g. [3-[(Cyclopropanecarbonyl-amino)-methyl]-pyrrolidin-1-yl}-(2-fluoro-benzyl)-propyl]-carbamic acid tert-butyl ester; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes; |
| 07/24/2008 | US20080176251 Preparation of high purity phenothiazine N-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase acitivity |
| 07/23/2008 | EP1947093A1 Substituted morpholine and thiomorpholine derivatives |
| 07/22/2008 | US7402414 Enzymatic process for deacetylation of a phenoxy-alkynyl acetate to the corresponding alcohol |
| 07/17/2008 | US20080171737 Cyclic sulfonamide derivatives and methods of their use |
| 07/16/2008 | EP1944607A2 Toluidine blue O compounds and their manufacture, analysis and use |
| 07/16/2008 | CN101220005A Method for producing benzo thiazides compounds |
| 07/09/2008 | EP1942105A1 Aminodihydrothiazine derivative |
| 07/09/2008 | EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c |
| 07/09/2008 | CN100400522C Novel charge transport materials having heteroaromatic hydrazone groups |
| 07/03/2008 | WO2008079371A1 Modulators of c3a receptor and methods of use thereof |
| 07/03/2008 | CA2671766A1 Modulators of c3a receptor and methods of use thereof |
| 07/02/2008 | CN101210013A Lewis acid catalysis aminolysis method for synthesizing piroxicam |
| 07/02/2008 | CN100398154C Remedies for psychoneurosis |
| 07/01/2008 | US7393852 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects |
| 07/01/2008 | US7393843 amyloid precursor protein and gamma -secretase inhibitor; 3,4,6,7,8,9-Hexahydro-2-methyl-3-oxo-2H-naphtho[2,3-e]-1,2-thiazine-4-carboxanilide 1,1-dioxide; neurodegenerative disease: Alzheimer's disease, amyloid plaque, Parkinson's disease, Down's syndrome, hemorrhage, arteriosclerosis |
| 06/26/2008 | WO2008075006A1 Piperldinum compounds for treatment of obstructive pulmonary diseases ( copd) |
| 06/25/2008 | EP1934232A2 Pyrrolo-thiazines and processes for the preparation and use thereof |
| 06/25/2008 | EP1730127B1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 06/19/2008 | WO2008073956A2 Cyclic sulfonamide derivatives and methods of their use |
| 06/17/2008 | CA2369947C Hydroxamic acid derivative |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139541 amyloid precursor protein and gamma -secretase inhibitor; 3,4,6,7,8,9-Hexahydro-2-methyl-3-oxo-2H-naphtho[2,3-e]-1,2-thiazine-4-(4-chloro)carboxanilide 1,1-dioxide; neurodegenerative disease: Alzheimer's disease, amyloid plaque, Parkinson's disease, Down's syndrome, hemorrhage, arteriosclerosis |
| 06/12/2008 | US20080139540 Antibacterial Agents |
| 06/12/2008 | US20080139539 6-{[(2-{4-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-1-piperazinyl}ethyl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 06/11/2008 | EP1727809B1 Substituted morpholine and thiomorpholine derivatives |
| 06/10/2008 | US7384939 N-(3,5-bis-trifluoromethyl-benzyl)-N-methyl-6-morpholin-4yl-4-o-tolyl-nicotinamide; inhibit interaction of substance P and neurokinin NK-1 receptor site; antiinflammatory; cyclization of amidoethyl-pyridinium salt with cyanoaryl-acrylate followed by amination, hydrogenation, hydrolysis; good yield |
| 06/05/2008 | WO2008066097A1 Carboxylic acid derivative |
| 06/05/2008 | US20080132697 N-[3-substituted piperazino] alkylphenothiazines; antiproliferative agents, apoptotic agents; 5-HT receptor antagonists |
| 06/05/2008 | CA2671080A1 Carboxylic acid derivatives |
| 06/04/2008 | EP1480967B1 Fused ring compounds, and their use as cationic photoinitiators |
| 06/03/2008 | US7381260 Thiazineindigo pigment dispersant, and pigment composition, colored composition and color filter, using the same |
| 05/29/2008 | WO2008062740A1 Nitrogenated fused ring compound and use thereof |
| 05/27/2008 | US7378428 phosphodiesterase inhibitors; (Z)-2-(7-bromomethyl-3,3-dimethyl-3,4-dihydro-(2H)-isoquinolin-1-ylidene)-1-(adamantan-1-yl)ethan-1-one; graft versus host disease, osteoporosis, bone fracture, restenosis, arteriosclerosis, obesity, ischemic reperfusion injury, depression, allergies, transplant rejection |
| 05/22/2008 | US20080119647 Process for the Purification of Meloxicam |
| 05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
| 05/20/2008 | US7375220 Method of treating diseases and conditions associated with an altered level of amyloid β peptides and new enolcarboxamide compounds |
| 05/15/2008 | US20080113975 Thiourea compounds |